Otsuka Canada Pharmaceutical, Inc.

Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, cardio-renal, and oncology. OCPI is dedicated to improving patients' health and the quality of human life.

CEO

Allison Rosenthal

GENERAL MANAGER

Allison was named General Manager of Otsuka Canada Pharmaceutical, Inc. in April 2013. Prior to holding this position, Allison worked as the Vice President of the Virology Immunology Business Unit for Bristol-Myers Squibb.

View Bio

EXPLORE

WEBSITE CAREERS NEWS

CONTACT

2250 Alfred-Nobel Boulevard,
St-Laurent, Quebec,
Suite 301
H4S 2C9

Tel: 1-888-997-9017

Fax: 1-514-332-3107